Logotipo do repositório
 

Publicação:
Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma

dc.contributor.authorConceição, André Luis Giacometti [UNESP]
dc.contributor.authorDa Silva, Camila Tainah
dc.contributor.authorBadial, Rodolfo Miglioli [UNESP]
dc.contributor.authorValsechi, Marina Curado [UNESP]
dc.contributor.authorStuqui, Bruna [UNESP]
dc.contributor.authorGonçalves, Jéssica Domingues
dc.contributor.authorJasiulionis, Miriam Galvonas
dc.contributor.authorDe Freitas Calmon, Marilia [UNESP]
dc.contributor.authorRahal, Paula [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2018-12-11T17:31:30Z
dc.date.available2018-12-11T17:31:30Z
dc.date.issued2017-03-01
dc.description.abstractClear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer. This carcinoma is histologically characterized by the presence of clear and abundant cytoplasm. In the present study, we sought to identify genes differentially expressed in ccRCC and build a molecular profile of this cancer. We selected genes described in the literature related to cellular differentiation and proliferation. We analyzed the gene and protein expression by quantitative PCR (qPCR) and immunohistochemistry, respectively, and examined possible epigenetic mechanisms that regulate their expression in ccRCC samples and cell lines. Occludin (OCLN) and growth arrest-specific 1 (GAS1) genes were underexpressed in ccRCC, and we report that miR-122 and miR-34a, respectively, may regulate their expression in this cancer. Furthermore, we showed by qPCR and immunohistochemistry that solute carrier family 2 member 1 (SLC2A1) was significantly overexpressed in ccRCC. The set of genes identified in the present study furthers our understanding of the molecular basis and development of ccRCC.en
dc.description.affiliationLaboratory of Genomic Studies Department of Biology São Paulo State University (UNESP), 2265 Cristóvão Colombo
dc.description.affiliationDepartment of Pharmacology Federal University of São Paulo (UNIFESP)
dc.description.affiliationUnespLaboratory of Genomic Studies Department of Biology São Paulo State University (UNESP), 2265 Cristóvão Colombo
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdFAPESP: 2012/08853-0
dc.format.extent1487-1496
dc.identifierhttp://dx.doi.org/10.3892/or.2017.5414
dc.identifier.citationOncology Reports, v. 37, n. 3, p. 1487-1496, 2017.
dc.identifier.doi10.3892/or.2017.5414
dc.identifier.issn1791-2431
dc.identifier.issn1021-335X
dc.identifier.lattes7991082362671212
dc.identifier.orcid0000-0001-5693-6148
dc.identifier.scopus2-s2.0-85013249473
dc.identifier.urihttp://hdl.handle.net/11449/178656
dc.language.isoeng
dc.relation.ispartofOncology Reports
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectChIP
dc.subjectClear cell renal cell carcinoma
dc.subjectEpigenetic
dc.subjectGene expression
dc.subjectImmunohistochemistry
dc.subjectMiRNA
dc.titleDownregulation of OCLN and GAS1 in clear cell renal cell carcinomaen
dc.typeArtigo
dspace.entity.typePublication
unesp.author.lattes7991082362671212[9]
unesp.author.orcid0000-0001-5693-6148[9]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Biociências Letras e Ciências Exatas, São José do Rio Pretopt
unesp.departmentBiologia - IBILCEpt

Arquivos